Dr. Nelson Shu-sang Yee MD
Hematologist-Oncologist | Hematology & Oncology
500 University Dr Hershey PA, 17033About
Dr. Nelson Yee is a hematologist oncologist practicing in Hershey, PA. Dr. Yee specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Jawaharlal Institute of Post Graduate Medicine Research, Pondicherry University 1995
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Zebrafish as a model for pancreatic cancer research.
- Exocrine pancreas development in zebrafish.
- Mutation of RNA Pol III subunit rpc2/polr3b Leads to Deficiency of Subunit Rpc11 and disrupts zebrafish digestive development.
- Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer.
- Transient receptor potential channel TRPM8 is over-expressed and required for
- Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapy.
- Transient receptor potential ion channel Trpm7 regulates exocrine pancreatic epithelial proliferation by Mg2+-sensitive Socs3a signaling in development and cancer.
- Histone deacetylase 1 is required for exocrine pancreatic epithelial proliferation in development and cancer.
- Brca2 deficiency and Trp53 deregulation in pancreatic cancer: implications for therapeutic targeting.
- Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma.
- TRPM8 ion channel is aberrantly expressed and required for preventing replicative senescence in pancreatic adenocarcinoma: potential role of TRPM8 as a biomarker and target.
- Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype.
- Translating discovery in zebrafish pancreatic development to human pancreatic cancer: biomarkers, targets, pathogenesis, and therapeutics.
- TRPM7 and TRPM8 Ion Channels in Pancreatic Adenocarcinoma: Potential Roles as Cancer Biomarkers and Targets.
- Aberrantly Over-Expressed TRPM8 Channels in Pancreatic Adenocarcinoma: Correlation with Tumor Size/Stage and Requirement for Cancer Cells Invasion.
Clinical Trials
Awards
- National Institutes of Health Mentored Clinical Scientist Development Award
- Doctor of Philosophy (Molecular Biology)
- Robert Wood Johnson, Jr. Charitable Trust Medical Scientist Training Program Fellowship
- Dana-Farber Cancer Institute American Cancer Society Alvan T. and Viola D. Fuller Jr. Research Fel
Treatments
- Pancreatic Cancer, Esophageal Cancer, Stomach Cancer
- Liver Cancer
- Pancreatic Cancer
- Colon Cancer
- Bile Duct Cancer
- Aerolase® Technologies
Fellowships
- Hosp. of the Univ. of PA-Hematology/Onc., Philadelphia, PA 2001
- Hematology/Oncology, Hospital of the University of Pennsylvania 2001
Dr. Nelson Shu-sang Yee MD's Practice location
Dr. Nelson Shu-sang Yee MD's reviews
Write ReviewPatient Experience with Dr. Yee
Recommended Articles
- Teen Treated for Lymphoma to Play College Baseball
Whether it’s the Dodgers or the Red Sox or the local high school team, they’re called ‘the boys of summer’.While summer is when the teams begin competitive play, they are very much the boys of spring as well.The temperature might be cool, but the air is sweet with promise.The players pull...
- Tips on How to Live with Multiple Myeloma
Multiple myeloma, a type of cancer, adversely affects plasma cells, which are your immune system’s components. The American Cancer Society indicates that in 2014, more than 24,000 people in the United States had multiple myeloma.Multiple myeloma patients can lose their appetite due to the adverse...
- Living with Lymphoma Day by Day
A majority of individuals diagnosed with lymphoma find that they have to make a great deal of adjustments to their lives. There are several physical, emotional, social, and everyday obstacles from diagnosis to remission.Living with lymphoma can be different for every individual, which is why it is...
- How This Survivor Star Beat Hodgkin Lymphoma—Twice
Ethan Zohn is a survivor in many ways. In 2002, he outlasted 15 fiercely strong competitors on the popular TV show, Survivor: Africa. His strength, wit, athleticism, and perseverance won him a million-dollar prize after he defeated these opponents. However, his victory was short-lived. Little did he...
- The Lymphoma Research Foundation's Light it Red for Lymphoma Night
Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...
- How to Deal with Lymphoma Treatment Fatigue
Treatment fatigue is a very common problem among lymphoma patients. Whether the patient is doing pharmaceutical treatments, chemotherapy, or other treatments, they will likely lead to fatigue and a feeling of being burnt out.This article will go over what treatment fatigue is, symptoms that are...
Nearby Providers
- Dr. Hyatt Peter DeGreen D.O.500 University Dr Hershey PA 17033
- Dr. Elliot Mark Epner MD500 University Dr Hershey PA 17033
- Dr. Jeffrey Paul Allerton MD500 University Dr Hershey PA 17033
- Dr. Jeffrey J. Pu M.D.500 University Dr Hershey PA 17033
- Dr. Chandra P Belani MD500 University Dr Hershey PA 17033
- Dr. Cristina I Truica M.D.500 University Dr Hershey PA 17033